期刊论文详细信息
Journal of the Brazilian Chemical Society
Synthesis and in vitro evaluation of novel galactosyl-triazolo-benzenesulfonamides against Trypanosoma cruzi
Andrade, Peterson de1  Lopes, Carla D.1  Silva, João S.1  Universidade de São Paulo, Ribeirão Preto, Brazil1  Junqueira, Getúlio G.1  Sesti-Costa, Renata1  Carvalho, Ivone1  Carvalho, Marcelo R.1  Carneiro, Zumira A.1 
关键词: Chagas disease;    Trypanosoma cruzi;    trans-sialidase;    benzenesulfonamides;    click chemistry;   
DOI  :  10.5935/0103-5053.20140158
学科分类:化学(综合)
来源: SciELO
PDF
【 摘 要 】

The only drugs approved for the treatment of Chagas disease, nifurtimox and benznidazole, present toxic side effects and limited efficacy in the chronic stage of the disease, which highlight the need for new drugs. Amongst the different molecular drug targets discovered in the parasite, Trypanosoma cruzi trans-sialidase (TcTS) has been considered crucial in the recognition and invasion of host cells. Hence, we report the efficient synthesis and biological evaluation (TcTS inhibition and antitrypanosomal activities) of some galactose-containing triazol-arylsulfonamides via microwave-assisted Cu(I) 1,3-dipolar azide-alkyne cycloaddition (CuAAC) based on azide benzenesulfonamides and a galactose-derived alkyne as precursors. Most of the compounds tested against TcTS showed moderate to weak inhibition (40%-15%), except one of the compounds (81%). Regarding the antitrypanosomal assay, some compounds [(IC50 70.9 µM) and (IC50 44.0 µM)] exhibited the most significant activities, although not as active as benznidazole (IC50 1.4 µM). Nevertheless, the cytotoxicity assessment showed that all compounds were not cytotoxic. In this preliminary work, we considered some compounds as lead scaffolds for further optimization.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201912050582035ZK.pdf 5344KB PDF download
  文献评价指标  
  下载次数:23次 浏览次数:8次